Zurich Cantonal Bank’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$331K Sell
19,128
-763
-4% -$13.2K ﹤0.01% 1899
2025
Q1
$435K Sell
19,891
-457
-2% -$10K ﹤0.01% 1681
2024
Q4
$649K Buy
20,348
+1,136
+6% +$36.3K ﹤0.01% 1477
2024
Q3
$554K Sell
19,212
-402
-2% -$11.6K ﹤0.01% 1499
2024
Q2
$752K Buy
19,614
+2,635
+16% +$101K ﹤0.01% 1211
2024
Q1
$998K Sell
16,979
-3,144
-16% -$185K ﹤0.01% 1065
2023
Q4
$1.2M Buy
20,123
+6,102
+44% +$365K ﹤0.01% 969
2023
Q3
$533K Buy
14,021
+1,310
+10% +$49.8K ﹤0.01% 1362
2023
Q2
$1.16M Buy
12,711
+1,050
+9% +$95.7K 0.01% 880
2023
Q1
$769K Buy
11,661
+1,026
+10% +$67.7K ﹤0.01% 1031
2022
Q4
$550K Sell
10,635
-880
-8% -$45.5K ﹤0.01% 1208
2022
Q3
$786K Buy
11,515
+1,107
+11% +$75.6K ﹤0.01% 939
2022
Q2
$471K Sell
10,408
-1,219
-10% -$55.2K ﹤0.01% 1261
2022
Q1
$591K Sell
11,627
-2,042
-15% -$104K ﹤0.01% 1248
2021
Q4
$646K Buy
13,669
+6,353
+87% +$300K ﹤0.01% 1267
2021
Q3
$241K Buy
7,316
+13
+0.2% +$428 ﹤0.01% 1796
2021
Q2
$462K Buy
7,303
+82
+1% +$5.19K ﹤0.01% 1272
2021
Q1
$310K Sell
7,221
-905
-11% -$38.9K ﹤0.01% 1523
2020
Q4
$465K Hold
8,126
﹤0.01% 1331
2020
Q3
$245K Hold
8,126
﹤0.01% 1458
2020
Q2
$265K Buy
8,126
+3,385
+71% +$110K ﹤0.01% 1347
2020
Q1
$127K Buy
4,741
+700
+17% +$18.8K ﹤0.01% 1467
2019
Q4
$124K Buy
4,041
+1,657
+70% +$50.8K ﹤0.01% 1588
2019
Q3
$57K Sell
2,384
-560
-19% -$13.4K ﹤0.01% 1942
2019
Q2
$75K Buy
2,944
+1,099
+60% +$28K ﹤0.01% 1788
2019
Q1
$36K Sell
1,845
-1,058
-36% -$20.6K ﹤0.01% 2178
2018
Q4
$38K Buy
2,903
+1,785
+160% +$23.4K ﹤0.01% 2179
2018
Q3
$20K Buy
+1,118
New +$20K ﹤0.01% 2473